EGFR and lung carcinoma: Therefore, their inhibitory effects on EGFR activity were evaluated by performing an ELISA to measure the phosphorylation level of the autophosphorylation site (i.e., the EGFR Y1068 residue) in gefitinib-resistant H1975 lung cancer cells.